OVEREXPRESSION OF P53 PROTEIN IN BARRETTS SYNDROME WITH MALIGNANT TRANSFORMATION

被引:72
作者
FLEJOU, JF
POTET, F
MUZEAU, F
LEPELLETIER, F
FEKETE, F
HENIN, D
机构
[1] HOP BEAUJON, DEPT PATHOL, F-92118 CLICHY, FRANCE
[2] HOP BEAUJON, DEPT DIGEST SURG, F-92118 CLICHY, FRANCE
[3] UNIV PARIS 07, INSERM, U239, PARIS, FRANCE
关键词
D O I
10.1136/jcp.46.4.330
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To study the overexpression of p53 protein in Barrett's oesophagus with adenocarcinoma, and to correlate this expression with the pathological features of Barrett's syndrome. Methods-Immunohistochemical staining was performed on frozen sections with a monoclonal antibody directed against wild type and mutated p53 protein (Pab 1801). Eleven cases of Barrett's adenocarcinoma were studied, seven of which had extensive sampling of benign Barrett's mucosa. Results-Eight of 11 adenocarcinomas overexpressed the p53 protein. Both early and advanced tumours were positive. In Barrett's mucosa around the p53 positive tumours, high grade dysplasia was positive; low grade dysplasia and non-dysplastic mucosa were negative. Conclusions-P53 gene mutation with ensuing p53 protein overexpression is a common feature of Barrett's adenocarcinoma, both at early and advanced stages. This mutation appears as a relatively late event during the neoplastic transformation of Barrett's oesophagus.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 30 条
  • [1] HIGH-GRADE DYSPLASIA IN THE COLUMNAR-LINED ESOPHAGUS
    ALTORKI, NK
    SUNAGAWA, M
    LITTLE, AG
    SKINNER, DB
    [J]. AMERICAN JOURNAL OF SURGERY, 1991, 161 (01) : 97 - 100
  • [2] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [3] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [4] BARTEK J, 1991, ONCOGENE, V6, P1699
  • [5] PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO
    BARTEK, J
    BARTKOVA, J
    VOJTESEK, B
    STASKOVA, Z
    REJTHAR, A
    KOVARIK, J
    LANE, DP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) : 839 - 844
  • [6] CAMPO E, 1991, CANCER RES, V51, P4436
  • [7] CASSON AG, 1991, CANCER RES, V51, P4495
  • [8] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [9] BARRETTS ESOPHAGUS - DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA
    HAMEETEMAN, W
    TYTGAT, GNJ
    HOUTHOFF, HJ
    VANDENTWEEL, JG
    [J]. GASTROENTEROLOGY, 1989, 96 (05) : 1249 - 1256
  • [10] THE RELATIONSHIP BETWEEN COLUMNAR EPITHELIAL DYSPLASIA AND INVASIVE ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS
    HAMILTON, SR
    SMITH, RRL
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) : 301 - 312